Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Rev Med Interne ; 45(3): 180-182, 2024 Mar.
Article in French | MEDLINE | ID: mdl-38479981

Subject(s)
Skin , Sweet Syndrome , Humans , Erythema
2.
Br J Haematol ; 74(1): 17-23, 1990 Jan.
Article in English | MEDLINE | ID: mdl-2178671

ABSTRACT

The effects of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) on neutrophil lactoferrin (LF) and transcobalamin (TC) 1 and 3 secretion were determined in vitro and during in vivo administration in humans. In whole blood, in vitro incubation with GM-CSF reproducibly produced a rise in plasma LF concentration (P less than 0.05) whereas in purified neutrophils the results were variable. Exposure of whole blood to GM-CSF also resulted in a significant rise in plasma TC 1 and 3 (190 +/- 60%, P less than 0.05). The response was dose dependent with maximal effect at GM-CSF concentrations of 10 ng/ml and above. rhGM-CSF was administered on seven occasions to six patients with malignant disease prior to chemotherapy. Plasma LF and unsaturated TC 1 and 3 levels rose significantly in each patient studied and the rise coincided with the initial neutropenia due to margination that occurs during infusions of rhGM-CSF. Patients receiving rhGM-CSF may therefore have hypofunctional neutrophils due to secondary granule depletion.


Subject(s)
Colony-Stimulating Factors/pharmacology , Cytoplasmic Granules/metabolism , Growth Substances/pharmacology , Neutrophils/metabolism , Cell Adhesion/physiology , Cells, Cultured , Dose-Response Relationship, Drug , Granulocyte-Macrophage Colony-Stimulating Factor , Humans , Kinetics , Lactoferrin/blood , Neutrophils/physiology , Transcobalamins/analysis
3.
Br J Haematol ; 71(3): 323-30, 1989 Mar.
Article in English | MEDLINE | ID: mdl-2649137

ABSTRACT

The administration of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) causes a transient leucopenia. Radionuclide labelling studies showed this to be due to margination of neutrophils and monocytes predominantly in the pulmonary vasculature. No evidence of complement activation was found. A rapid in-vivo rise in neutrophil cellular adhesion molecule (CAM) expression was observed paralleling the development of the neutropenia. Neutrophils exposed to rhGM-CSF in-vitro showed similar rapid increases in CAM expression. The adherence of chromium-labelled neutrophils to endothelial cell cultures was modestly but highly significantly increased by rhGM-CSF, an effect that was reduced by the binding of a monoclonal antibody to the beta chain of neutrophil CAM. The margination of phagocytic cells induced by rhGM-CSF administration is therefore likely to be due at least in part to increased expression of adhesion promoting glycoproteins. The demargination, however, occurred at a time when neutrophil CAM expression was still high, suggesting that dissociation of the neutrophil-endothelial cell interaction depends on factors other than downregulation of CAM expression. In-vivo modulation of phagocyte CAMS and adhesive properties by GM-CSF may be of importance in the normal inflammatory response.


Subject(s)
Antigens, Surface/analysis , Colony-Stimulating Factors/adverse effects , Growth Substances/adverse effects , Leukopenia/etiology , Cell Adhesion , Cell Adhesion Molecules , Endothelium/physiopathology , Granulocyte-Macrophage Colony-Stimulating Factor , Hodgkin Disease/therapy , Humans , Leukocyte Count , Leukopenia/physiopathology , Monocytes/physiology , Neoplasms/therapy , Neutrophils/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...